| Dr Sarah G Cagino, MD | |
|
400 Patroon Creek Blvd Ste 102, Albany, NY 12206-5015 | |
| (518) 445-4320 | |
| (518) 475-7050 |
| Full Name | Dr Sarah G Cagino |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology - Maternal & Fetal Medicine |
| Location | 400 Patroon Creek Blvd Ste 102, Albany, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356735716 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 300653 (New York) | Primary |
| Entity Name | Samaritan Hospital Of Troy, New York |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043267727 PECOS PAC ID: 6507770070 Enrollment ID: O20031118000782 |
News Archive
A ten-year NIH-funded study has determined that a third of infants with prolonged seizures and fever suffer from either a new or reactivated roseola virus infection. Roseola viruses are the cause of the common childhood rash, but can also cause limbic encephalitis, a condition that frequently progresses to epilepsy. Investigators discovered one of the roseola viruses, human herpesvirus-6B (HHV-6B) in the blood of 32% of 169 infants with prolonged seizures, a condition known as status epilepticus.
In a bid to help clarify the all-but-transparent requirements needed In a bid to help clarify the all-but-transparent requirements needed to produce a compliant Clinical Evaluation Report (CER), Maetrics, a leading international consulting firm focused on the life sciences sector, has drafted a free go-to guide for Medical Device manufacturers downloadable here: Maetrics guide.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that it has initiated a Phase I clinical trial of its lead compound GLYX-13 and has successfully dosed the first subjects in the study.
The Department of Health and Human Services announced Wednesday a new initiative created by the health law that will ask physicians to focus on patients with chronic conditions. The program will be tested in five to seven markets across the country.
› Verified 9 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
A ten-year NIH-funded study has determined that a third of infants with prolonged seizures and fever suffer from either a new or reactivated roseola virus infection. Roseola viruses are the cause of the common childhood rash, but can also cause limbic encephalitis, a condition that frequently progresses to epilepsy. Investigators discovered one of the roseola viruses, human herpesvirus-6B (HHV-6B) in the blood of 32% of 169 infants with prolonged seizures, a condition known as status epilepticus.
In a bid to help clarify the all-but-transparent requirements needed In a bid to help clarify the all-but-transparent requirements needed to produce a compliant Clinical Evaluation Report (CER), Maetrics, a leading international consulting firm focused on the life sciences sector, has drafted a free go-to guide for Medical Device manufacturers downloadable here: Maetrics guide.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that it has initiated a Phase I clinical trial of its lead compound GLYX-13 and has successfully dosed the first subjects in the study.
The Department of Health and Human Services announced Wednesday a new initiative created by the health law that will ask physicians to focus on patients with chronic conditions. The program will be tested in five to seven markets across the country.
› Verified 9 days ago
| Entity Name | St Peters Hospital Of The City Of Albany |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518042357 PECOS PAC ID: 2668460072 Enrollment ID: O20040504001301 |
News Archive
A ten-year NIH-funded study has determined that a third of infants with prolonged seizures and fever suffer from either a new or reactivated roseola virus infection. Roseola viruses are the cause of the common childhood rash, but can also cause limbic encephalitis, a condition that frequently progresses to epilepsy. Investigators discovered one of the roseola viruses, human herpesvirus-6B (HHV-6B) in the blood of 32% of 169 infants with prolonged seizures, a condition known as status epilepticus.
In a bid to help clarify the all-but-transparent requirements needed In a bid to help clarify the all-but-transparent requirements needed to produce a compliant Clinical Evaluation Report (CER), Maetrics, a leading international consulting firm focused on the life sciences sector, has drafted a free go-to guide for Medical Device manufacturers downloadable here: Maetrics guide.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that it has initiated a Phase I clinical trial of its lead compound GLYX-13 and has successfully dosed the first subjects in the study.
The Department of Health and Human Services announced Wednesday a new initiative created by the health law that will ask physicians to focus on patients with chronic conditions. The program will be tested in five to seven markets across the country.
› Verified 9 days ago
| Entity Name | St. Peter's Health Partners Medical Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626834 PECOS PAC ID: 6103061189 Enrollment ID: O20130321000567 |
News Archive
A ten-year NIH-funded study has determined that a third of infants with prolonged seizures and fever suffer from either a new or reactivated roseola virus infection. Roseola viruses are the cause of the common childhood rash, but can also cause limbic encephalitis, a condition that frequently progresses to epilepsy. Investigators discovered one of the roseola viruses, human herpesvirus-6B (HHV-6B) in the blood of 32% of 169 infants with prolonged seizures, a condition known as status epilepticus.
In a bid to help clarify the all-but-transparent requirements needed In a bid to help clarify the all-but-transparent requirements needed to produce a compliant Clinical Evaluation Report (CER), Maetrics, a leading international consulting firm focused on the life sciences sector, has drafted a free go-to guide for Medical Device manufacturers downloadable here: Maetrics guide.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that it has initiated a Phase I clinical trial of its lead compound GLYX-13 and has successfully dosed the first subjects in the study.
The Department of Health and Human Services announced Wednesday a new initiative created by the health law that will ask physicians to focus on patients with chronic conditions. The program will be tested in five to seven markets across the country.
› Verified 9 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
A ten-year NIH-funded study has determined that a third of infants with prolonged seizures and fever suffer from either a new or reactivated roseola virus infection. Roseola viruses are the cause of the common childhood rash, but can also cause limbic encephalitis, a condition that frequently progresses to epilepsy. Investigators discovered one of the roseola viruses, human herpesvirus-6B (HHV-6B) in the blood of 32% of 169 infants with prolonged seizures, a condition known as status epilepticus.
In a bid to help clarify the all-but-transparent requirements needed In a bid to help clarify the all-but-transparent requirements needed to produce a compliant Clinical Evaluation Report (CER), Maetrics, a leading international consulting firm focused on the life sciences sector, has drafted a free go-to guide for Medical Device manufacturers downloadable here: Maetrics guide.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that it has initiated a Phase I clinical trial of its lead compound GLYX-13 and has successfully dosed the first subjects in the study.
The Department of Health and Human Services announced Wednesday a new initiative created by the health law that will ask physicians to focus on patients with chronic conditions. The program will be tested in five to seven markets across the country.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah G Cagino, MD Po Box 14890, Albany, NY 12212-4890 Ph: (518) 525-5634 | Dr Sarah G Cagino, MD 400 Patroon Creek Blvd Ste 102, Albany, NY 12206-5015 Ph: (518) 445-4320 |
News Archive
A ten-year NIH-funded study has determined that a third of infants with prolonged seizures and fever suffer from either a new or reactivated roseola virus infection. Roseola viruses are the cause of the common childhood rash, but can also cause limbic encephalitis, a condition that frequently progresses to epilepsy. Investigators discovered one of the roseola viruses, human herpesvirus-6B (HHV-6B) in the blood of 32% of 169 infants with prolonged seizures, a condition known as status epilepticus.
In a bid to help clarify the all-but-transparent requirements needed In a bid to help clarify the all-but-transparent requirements needed to produce a compliant Clinical Evaluation Report (CER), Maetrics, a leading international consulting firm focused on the life sciences sector, has drafted a free go-to guide for Medical Device manufacturers downloadable here: Maetrics guide.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that it has initiated a Phase I clinical trial of its lead compound GLYX-13 and has successfully dosed the first subjects in the study.
The Department of Health and Human Services announced Wednesday a new initiative created by the health law that will ask physicians to focus on patients with chronic conditions. The program will be tested in five to seven markets across the country.
› Verified 9 days ago
Dr. Cheryl B Burack, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 62 Hackett Blvd, Albany, NY 12209 Phone: 518-465-7062 Fax: 518-449-1378 | |
Alexis Joanna Disilvestro, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 400 Patroon Creek Blvd Ste 102, Albany, NY 12206 Phone: 518-445-4325 | |
Benjamin Margolis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 391 Myrtle Ave Ste 200, Albany, NY 12208 Phone: 518-262-4942 Fax: 518-262-5291 | |
Corinne Mcleod, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 391 Myrtle Ave Ste 2, Albany, NY 12208 Phone: 518-264-4942 | |
Caitlin Wood Parrott, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 400 Patroon Creek Blvd Ste 102, Albany, NY 12206 Phone: 518-445-4320 Fax: 518-475-7050 | |
Dr. Ryan Dennis Cuff, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 400 Patroon Creek Blvd Ste 102, Albany, NY 12206 Phone: 518-445-4325 | |
Peter Namkoong, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1365 Washington Ave, Suite 201, Albany, NY 12206 Phone: 518-489-4446 Fax: 518-489-4448 |